Country - Germany
Summary - Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - In All Potencies Except 2.5 Mg Per Divided Oral Dosage Form)
Deadline - Apr 30, 2026
MT reference number - 82043435
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 82043435
Document Type - Tender Notices
Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the Social Code Book V for finished medicinal products containing the active ingredient rivaroxaban (ATC: B01A F01 - in all strengths except 2.5 mg per divided oral dosage form) within the framework of a so-called "open-house model". Under the specification of uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or groups of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the aforem
Mt Ref Id - 82043435
Deadline - Apr 30, 2026
Similar Tenders :
Healthcare and Medicine